Fund Holdings — B Group, Inc.

Total Portfolio Value
$104.58M
Total Bought
$16.38M
Total Sold
$16.84M
Net Transaction
-$456.3K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
NRX PHARMACEUTICALS INC(NRXP)03,000,000+3,000,00004,4554.26%+4,455
CELLECTIS S A(CLLS)3,256,5013,281,501+25,0004,9669,3528.94%+4,386
TAYSHA GENE THERAPIES INC(TSHA)1,800,5561,800,55604,1595,8885.63%+1,729
ASSEMBLY BIOSCIENCES INC189,350175,706-13,6443,4314,4984.30%+1,067
IOVANCE BIOTHERAPEUTICS INC(IOVA)1,500,0001,500,00002,5803,2553.11%+675
ORUKA THERAPEUTICS INC(ORKA)75,00075,00008411,4421.38%+602
SPYRE THERAPEUTICS INC(SYRE)80,000100,000+20,0001,1981,6761.60%+478
PRAXIS PRECISION MEDICINES I(PRAX)35,00031,500-3,5001,4721,6701.60%+198
GAMESQUARE HLDGS INC(GAME)0250,000+250,00001700.16%+170
ULTRAGENYX PHARMACEUTICAL IN(RARE)110,000135,000+25,0004,0004,0613.88%+61
AURA BIOSCIENCES INC(AURA)572,576572,57603,5843,5393.38%-46
APOGEE THERAPEUTICS INC(APGE)35,00035,00001,5201,3911.33%-129
ZAI LAB LTD(ZLAB)400,000400,000013,98813,55612.96%-432
SIGHT SCIENCES INC(SGHT)930,000930,00003,8413,1993.06%-642
AKERO THERAPEUTICS INC232,446232,446012,40311,03710.55%-1,367
ADMA BIOLOGICS INC2,317,5422,412,542+95,00042,20235,36833.82%-6,835
INSMED INC(INSM)155,000158-154,84215,599230.02%-15,576
Page 1 of 1
B Group, Inc. — 13F Holdings — Q3 2025 | TickerTrail